Advanced in Glaucoma

Laurent P. Kodjikian

Villeurbanne, FR 
Advanced in Glaucoma
Villeurbanne, FR 
OverviewLocationsClinical Research

Overview

Laurent Kodjikian practices in Villeurbanne, France. Dr. Kodjikian is rated as an Advanced expert by MediFind in the treatment of Glaucoma. His top areas of expertise are Age-Related Macular Degeneration (ARMD), Late-Onset Retinal Degeneration, Diabetic Macular Edema (DME), Vitrectomy, and Cataract Removal.

His clinical research consists of co-authoring 374 peer reviewed articles and participating in 7 clinical trials. MediFind looks at clinical research from the past 15 years. In particular, he has co-authored 17 articles in the study of Glaucoma.

Gender
Male

Locations

Villeurbanne, France
Other Locations
Lyon, France
France
Paris, 75014, France
CHU Nantes
Nantes, France
Dijon, France

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

7 Clinical Trials

Phase II Study Evaluating the Efficacy of Aflibercept for the Treatment of Inflammatory Choroidal Neovascularization (CNV) in Young Patients.
Phase II Study Evaluating the Efficacy of Aflibercept for the Treatment of Inflammatory Choroidal Neovascularization (CNV) in Young Patients.
Enrollment Status: Completed
Publish Date: August 08, 2025
Intervention Type: Drug
Study Phase: Phase 2
Restoration of Central Vision With the PRIMA System in Patients With Atrophic Age-Related Macular Degeneration
Restoration of Central Vision With the PRIMA System in Patients With Atrophic Age-Related Macular Degeneration
Enrollment Status: Active_not_recruiting
Publish Date: November 29, 2024
Intervention Type: Device
Study Phase: Not Applicable
Amniotic Membrane Visio-AMTRIX in Recurrent Macular Hole
Amniotic Membrane Visio-AMTRIX in Recurrent Macular Hole
Enrollment Status: Terminated
Publish Date: May 01, 2023
Intervention Type: Biological
Study Drug: Visio-AMTRIX
Study Phase: Phase 2
A Prospective Multicenter, Comparative, Randomized, Double-blind, Non-inferiority Study of Eyestil® Plus Multidose Versus Vismed Multi® in Patients With Moderate to Severe Dry Eye Syndrome
A Prospective Multicenter, Comparative, Randomized, Double-blind, Non-inferiority Study of Eyestil® Plus Multidose Versus Vismed Multi® in Patients With Moderate to Severe Dry Eye Syndrome
Enrollment Status: Completed
Publish Date: December 23, 2022
Intervention Type: Device
Study Phase: Not Applicable
A Multicenter Randomized Open-label Trial Comparing the Efficacy and Safety of Infliximab Versus Cyclophosphamide in Subjects With Idiopathic Refractory Scleritis
A Multicenter Randomized Open-label Trial Comparing the Efficacy and Safety of Infliximab Versus Cyclophosphamide in Subjects With Idiopathic Refractory Scleritis
Enrollment Status: Withdrawn
Publish Date: July 20, 2022
Intervention Type: Drug
Study Drugs: Infliximab, Cyclophosphamide
Study Phase: Phase 3
Incidence of Macular Edema After Panretinal Photocoagulation (PRPC) Performed in a Single Session Versus Four Sessions in Diabetic Patients.
Incidence of Macular Edema After Panretinal Photocoagulation (PRPC) Performed in a Single Session Versus Four Sessions in Diabetic Patients.
Enrollment Status: Completed
Publish Date: December 27, 2018
Intervention Type: Procedure
Study Phase: Phase 3
Phase II Study Evaluating the Efficacy of Aflibercept for the Treatment of Choroidal Neovascularization in Angioid Streaks in Young Patients.
Phase II Study Evaluating the Efficacy of Aflibercept for the Treatment of Choroidal Neovascularization in Angioid Streaks in Young Patients.
Enrollment Status: Withdrawn
Publish Date: January 06, 2017
Intervention Type: Drug
Study Phase: Phase 2
View 6 Less Clinical Trials

374 Total Publications

Expanding the clinical spectrum of lysozyme-derived amyloidosis.
Expanding the clinical spectrum of lysozyme-derived amyloidosis.
Journal: Amyloid : the international journal of experimental and clinical investigation : the official journal of the International Society of Amyloidosis
Published: July 25, 2025

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Dr. Kodjikian's expertise for a condition
ConditionClose
View All 20 Advanced Conditions
View All 38 Experienced Conditions
Want to save this expert for later?
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
 
 
 
 
Learn about our expert tiers
Learn More
Are you the provider on this profile?
Claim Profile